Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

BACKGROUND: Long-term antiviral treatments are associated with a significantly lower hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients by reducing HBV DNA concentrations. However, it is still controversial whether antiviral strategies affect HCC development in antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ze-Hong, Lu, Gui-Yang, Qiu, Ling-Xian, Zhong, Guo-Hua, Huang, Yue, Yao, Xing-Mei, Liu, Xiao-Hui, Huang, Shou-Jie, Wu, Ting, Yuan, Quan, Wang, Ying-Bin, Su, Ying-Ying, Zhang, Jun, Xia, Ning-Shao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930063/
https://www.ncbi.nlm.nih.gov/pubmed/35300634
http://dx.doi.org/10.1186/s12885-022-09413-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930063/
https://www.ncbi.nlm.nih.gov/pubmed/35300634
http://dx.doi.org/10.1186/s12885-022-09413-7

Ejemplares similares